Basic and clinical concepts related to vitamin D metabolism and action (second of two parts).
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects; D001798:Blood Proteins / Q000378:metabolism; D002118:Calcium / Q000652:urine; D002128:Calcium Metabolism Disorders / Q000378:metabolism*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000378:metabolism; D004100:Dihydroxycholecalciferols / Q000378:metabolism; D006801:Humans; D006887:Hydroxycholecalciferols / Q000378:metabolism; D006996:Hypocalcemia / Q000378:metabolism; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism; D007684:Kidney Tubules; D008107:Liver Diseases / Q000378:metabolism; D008286:Malabsorption Syndromes / Q000378:metabolism; D010018:Osteomalacia / Q000139:chemically induced; D010024:Osteoporosis / Q000378:metabolism; D010279:Parathyroid Diseases / Q000378:metabolism; D010760:Phosphorus Metabolism Disorders / Q000378:metabolism*; D011485:Protein Binding; D011955:Receptors, Drug; D012279:Rickets / Q000378:metabolism; D014807:Vitamin D / Q000031:analogs & derivatives / Q000378:metabolism* / Q000506:poisoning / Q000627:therapeutic use
D000927:Anticonvulsants; D001798:Blood Proteins; D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D011955:Receptors, Drug; D014807:Vitamin D; D002118:Calcium